Evidence map›Paper›PMID 36033814›Full record

ArticleFrontiers in public health2022

Comparison of clinical outcomes and risk factors for COVID-19 infection in cancer patients without anticancer treatment and noncancer patients.

Sen Yang, Huaxin Zhao, Ran Cui, Le Ma, Xuhua Ge, Qiangqiang Fu, Dehua Yu, Xiaomin Niu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sen YangDepartment of General Practice, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, China.
Huaxin ZhaoDepartment of Oncology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Ran CuiDepartment of Rheumatology and Immunology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Le MaDepartment of General Practice, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, China.
Xuhua GeDepartment of General Practice, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, China.
Qiangqiang FuYangpu Hospital, Tongji University, Shanghai, China.
Dehua YuYangpu Hospital, Tongji University, Shanghai, China.
Xiaomin NiuDepartment of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Yangpu Hospital of Tongji University · CNShanghai Jiao Tong University · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Previous studies have shown that cancer patients have higher rates of coronavirus disease 2019 (COVID-19) infection and mortality than noncancer patients. However, the differences between cancer patients undergoing regular follow-up without anticancer treatment and noncancer patients with COVID-19 have remained insufficiently investigated. Methods: A retrospective case-control study of 52 patients with COVID-19 infection was performed with a 1:3 matched proportion of cancer patients undergoing regular follow-up without anticancer treatment and noncancer patients. The demographic characteristics, clinical data, laboratory tests, treatment, and complications of patients were collected from medical records. Chi-square tests and univariate and multivariate regressions were performed to assess the differences between these two cohorts of COVID-19 patients with and without cancer and risk factors for severe events in COVID-19 patients. Results: Increased C-reactive protein (CRP) (>4 mg/L) ( Conclusions: Increased CRP and LDH were risk factors for severe events in all enrolled COVID-19 patients, and an increased incidence of hypoalbuminemia complications and longer hospitalization were noted in COVID-19 cancer patients undergoing regular follow-up without anticancer treatment compared with noncancer patients.

Indexed as

COVID-19HypoalbuminemiaNeoplasmsCase-Control StudiesHumansRetrospective StudiesRisk FactorsSARS-CoV-2cancercoronavirus disease 2019C-reactive protein (CRP)follow-upsevere event risk

Identifiers

PMID36033814
PMCPMC9411742
OpenAlexW4291148138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.